These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6149425)

  • 1. Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma.
    Jüngst D
    Lancet; 1984 Nov; 2(8410):1043. PubMed ID: 6149425
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
    Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
    Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilisation hypercalcaemia in adults and treatment with clodronate.
    Yates AJ; Jones TH; Mundy KI; Hague RV; Brown CB; Guilland-Cumming D; Kanis JA
    Br Med J (Clin Res Ed); 1984 Oct; 289(6452):1111-2. PubMed ID: 6237713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monotherapy with clodronate for tumor-induced hypercalcemia].
    Harjung H; Fritze D
    Dtsch Med Wochenschr; 1990 Jan; 115(2):48-52. PubMed ID: 2136827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
    Lind L; Wengle B; Ljunghall S
    Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative normalization of hypercalcemia, caused by parathyroid cancer, by intravenous administration of dichloromethylene diphosphonate].
    Conte N; Di Virgilio R; Roiter I
    Minerva Endocrinol; 1984; 9(1):47-8. PubMed ID: 6239086
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
    Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
    Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of diphosphonates in hypercalcaemia due to malignancy.
    Kanis JA; McCloskey EV; Paterson AH
    Lancet; 1990 Jan; 335(8682):170-1. PubMed ID: 1967461
    [No Abstract]   [Full Text] [Related]  

  • 11. Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
    Witte RS; Koeller J; Davis TE; Benson AB; Durie BG; Lipton A; Stock JL; Citrin DL; Jacobs TP
    Arch Intern Med; 1987 May; 147(5):937-9. PubMed ID: 2953318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bisphosphonates in hypercalcaemia due to malignancy.
    Ralston SH; Gallacher SJ; Patel U; Fraser WD; Dryburgh FJ; Boyle IT
    Lancet; 1990 Mar; 335(8691):737. PubMed ID: 1969100
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of calcitonin and clodronate in hypercalcaemia.
    Ljunghall S; Rastad J; Akerström G
    Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
    Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
    Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
    Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
    Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bisphosphonate dilemma.
    Koyano H; Schimizu T; Shishiba Y
    J Nucl Med; 1995 Apr; 36(4):705-6. PubMed ID: 7699469
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypercalcemia during immobilization and prolonged anuria treated with disodium clodronate].
    Evald T; Jensen GV; Garde K
    Ugeskr Laeger; 1992 Jul; 154(31):2158-9. PubMed ID: 1387269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
    Scharla SH; Minne HW; Sattar P; Mende U; Blind E; Schmidt-Gayk H; Wüster C; Ho T; Ziegler R
    Dtsch Med Wochenschr; 1987 Jul; 112(28-29):1121-5. PubMed ID: 2956079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diphosphonates in the treatment of hypercalcemia].
    Delmas PD; Meunier PJ
    Rev Med Interne; 1984 Nov; 5(4):363-6. PubMed ID: 6240753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
    Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
    Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.